Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Deutsche Bank Starts Prothena Corp (PRTA) at Buy
November 3, 2016 6:49 AM EDTDeutsche Bank initiated coverage on Prothena Corp (NASDAQ: PRTA) with a Buy rating and a price target of $73. Analyst Andrew Peters sees Prothena as a "compelling story."
"We view PRTA as a fundamentally strong story with a well-spaced catalyst path across three clinical... More
